TONI, Giulia
 Distribuzione geografica
Continente #
EU - Europa 15.697
NA - Nord America 5.748
AS - Asia 3.430
SA - Sud America 523
Continente sconosciuto - Info sul continente non disponibili 213
AF - Africa 82
OC - Oceania 20
AN - Antartide 2
Totale 25.715
Nazione #
IT - Italia 13.098
US - Stati Uniti d'America 5.578
SG - Singapore 1.207
CN - Cina 845
NL - Olanda 563
DE - Germania 471
BR - Brasile 414
FR - Francia 361
VN - Vietnam 357
UA - Ucraina 323
HK - Hong Kong 256
TR - Turchia 215
GB - Regno Unito 184
FI - Finlandia 167
BD - Bangladesh 114
IN - India 103
RU - Federazione Russa 93
CA - Canada 82
JP - Giappone 79
CH - Svizzera 71
SE - Svezia 70
MX - Messico 61
ES - Italia 56
PL - Polonia 51
ID - Indonesia 45
AR - Argentina 36
BE - Belgio 27
IQ - Iraq 24
TH - Thailandia 21
RO - Romania 19
ZA - Sudafrica 19
AU - Australia 18
CO - Colombia 16
EC - Ecuador 16
AT - Austria 15
MY - Malesia 15
DK - Danimarca 14
IR - Iran 14
KR - Corea 14
LT - Lituania 14
MA - Marocco 14
PH - Filippine 14
AE - Emirati Arabi Uniti 13
CL - Cile 13
CZ - Repubblica Ceca 13
IE - Irlanda 13
PK - Pakistan 13
UZ - Uzbekistan 13
GR - Grecia 12
IL - Israele 12
SA - Arabia Saudita 12
BO - Bolivia 9
TW - Taiwan 8
VE - Venezuela 8
AL - Albania 7
JM - Giamaica 7
KE - Kenya 7
PT - Portogallo 7
TN - Tunisia 7
DZ - Algeria 6
EG - Egitto 6
JO - Giordania 6
MT - Malta 6
SK - Slovacchia (Repubblica Slovacca) 6
LB - Libano 5
NO - Norvegia 5
AZ - Azerbaigian 4
BY - Bielorussia 4
MD - Moldavia 4
OM - Oman 4
PE - Perù 4
UY - Uruguay 4
AO - Angola 3
CI - Costa d'Avorio 3
CY - Cipro 3
DO - Repubblica Dominicana 3
HR - Croazia 3
KZ - Kazakistan 3
LU - Lussemburgo 3
LV - Lettonia 3
NG - Nigeria 3
NP - Nepal 3
PA - Panama 3
PY - Paraguay 3
RS - Serbia 3
SI - Slovenia 3
SM - San Marino 3
AQ - Antartide 2
CR - Costa Rica 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
GT - Guatemala 2
HU - Ungheria 2
LY - Libia 2
NZ - Nuova Zelanda 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AG - Antigua e Barbuda 1
BB - Barbados 1
Totale 25.481
Città #
Milan 1.074
Rome 795
Singapore 743
Ashburn 603
San Jose 469
Fairfield 372
Woodbridge 319
Beijing 298
Chandler 271
Jacksonville 263
Santa Clara 263
Dallas 255
Hong Kong 246
Naples 222
Houston 209
Turin 195
Bologna 181
Florence 165
Ann Arbor 163
Seattle 156
Munich 153
Wilmington 148
Bari 140
Cambridge 136
Palermo 130
Izmir 123
Ho Chi Minh City 114
Brescia 108
Hanoi 101
Helsinki 96
Ferrara 93
Los Angeles 92
New York 89
Genoa 83
Catania 82
Nanjing 80
Verona 79
Tokyo 75
Bremen 65
Padova 65
Princeton 63
Lauterbourg 60
Perugia 60
Redwood City 60
Cagliari 58
Modena 58
Parma 54
Dearborn 51
Bergamo 47
Boardman 45
Council Bluffs 45
Shanghai 45
The Dalles 39
Reggio Emilia 38
São Paulo 38
Pescara 37
Venice 36
Chicago 35
Trento 35
Trieste 35
Monza 32
Salerno 32
Falkenstein 31
Orem 31
Toronto 31
Mexico City 30
Treviso 30
Pisa 29
San Diego 29
London 28
Napoli 28
Tianjin 27
Rimini 26
Amsterdam 25
Lucca 24
Mountain View 23
Warsaw 23
Nanchang 22
Taranto 22
Bolzano 21
Chennai 21
Moscow 21
Shenyang 20
Torino 20
Washington 20
Jiaxing 19
Montreal 18
Reggio Calabria 18
Vicenza 18
Cinisello Balsamo 17
Jakarta 17
Lamezia Terme 17
Livorno 17
Manchester 17
Afragola 16
Ancona 16
Como 16
Haiphong 16
Meda 16
Novara 16
Totale 11.153
Nome #
Ustioni da airbag: una problematica emergente 10.789
Maintenance therapy: A crucial strategy in acne treatment 1.568
Linfangioma circoscritto vulvare: quando le cose si complicano. 1.028
Cinquanta sfumature di blu. 594
Anti-infiammatori non steroidei nell’acne: quale razionale? 515
Possibili marcatori di malattia e prognosi nel lichen sclerosus vulvare: il contributo dell’epigenetica. 431
Clobetasol propionate vs. mometasone furoate in 1-year proactive maintenance therapy of vulvar lichen sclerosus: Results from a comparative trial 400
Anatomia e fisiologia dell’unità pilo-sebacea 323
null 309
Effect of Corticosteroid Phobia on Treatment Adherence and Outcome in Women With Lichen Sclerosus: A Prospective Study 274
Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: a prospective study on 23 patients. 227
Maintenance therapy for acne vulgaris: efficacy of a 12-month treatment with adapalene-benzoyl peroxide after oral isotretinoin and a review of the literature. 221
Safe use of oral isotretinoin after pseudo-tumor cerebri due to minocycline. 219
Insect repellents and contact sensitization: An observational study 218
Side-effects of tango: Connubial contact dermatitis 214
Clinical and dermoscopic changes of vulvar lichen sclerosus after topical corticosteroid treatment 205
Dermoscopy of patch test reactions: study of applicability in differential diagnosis between allergic and irritant reactions 205
Avocado and soybean extracts as active principles in the treatment of mild-to-moderate vulvar lichen sclerosus: Results of efficacy and tolerability 202
Clearance in vulvar lichen sclerosus: a realistic treatment endpoint or a chimera? 196
Combining topical tretinoin with mometasone furoate in the treatment of vulvar lichen sclerosus: Results of dermoscopic assessment 190
Efficacy and safety of a 12-month treatment with a combination of hydroxypinacolone retinoate and retinol glycospheres as maintenance therapy in acne patients after oral isotretinoin 181
Aromatherapy and occupational allergic contact dermatitis: Two further cases caused by lavender oil and other essential oils 180
Severe vulvovaginal allergic contact dermatitis due to clotrimazole contained in multiple topical products 180
Hidradenitis Suppurativa: The Effect Of Combinated Treatment With Oral Clindamycin And Rifampicin 178
Adapalene 0.1% / benzoyl peroxide 2.5% gel fixed combination after oral isotretinoin: evaluation of acne recurrence incidence. 178
Combined therapy in vulvar lichen sclerosus: does topical tretinoin improve the efficacy of mometasone furoate? 178
Acne e retinoidi: come e quando impiegarli. 172
An update on hidradenitis suppurativa treatment. 172
Systemic allergic dermatitis due to gentamicin 169
Mometasone furoate in the treatment of vulvar lichen sclerosus: could its formulation influence efficacy, tolerability and adherence to treatment? 167
Level of use and safety of botanical products for itching vulvar dermatoses. Are patch tests useful? 165
Consensus conference su isotretinoina orale. 159
I corticosteroidi sistemici nell’acne: perché, quando, come. 158
Cortisonici a confronto. 155
Plasma cell vulvitis: further confirmation of the diagnostic utility of dermoscopy 155
Cryogenic burn by cryolipolysis [Ustione a frigore da criolipolisi] 152
Low-cumulative dose isotretinoin treatment in mild to moderate acne. 151
Bullous irritant contact dermatitis caused by an alcoholic extract from Juglans regia leaves 151
null 149
Acne meccanica da tutore ortopedico. 149
What’s new in acne? New therapeutic approaches. 148
Patch test reactions through the lens of dermoscopy: Further insights, particularly on weak allergic reactions 147
La biopsia del corneo nello studio dei comedoni. 146
Prospective clinical and epidemiologic study of vulvar lichen sclerosus: analysis of prevalence and severity of clinical features, together with historical and demographic associations. 146
Mammary pigmented Paget's disease in a male: A diagnostic challenge 145
Cheiliti da contatto 139
Proposal for post-acne scar management algorithm. 138
Radiation-induced angiosarcoma of the breast: an uncommon polymorphic disorder 138
Does longer duration of corticosteroid treatment improve clearance in vulvar lichen sclerosus? Results from a single centre, comparative, open label study 137
Effectiveness of silk fabric underwear as an adjuvant tool in the management of vulvar lichen simplex chronicus: results of a double-blind randomized controlled trial 135
It looks like acne, but… 132
What treatments are on the horizon for acne. 128
Maintenance therapy in acne 126
Topical treatment of acne: immunomodulatory approaches. 123
Rosacea Fulminans. 122
Does Clearance of Vulvar Lichen Sclerosus after a Corticosteroid Treatment Correspond to a Decrease in Disease-Related Burden? Results from a Cohort Study Using Pictorial Representation of Illness and Self-Measure and the Dermatology Life Quality Index 120
Umbilical nodules: Two cases of atypical cutaneous endometriosis 116
Micosi profonda ed iperplasia pseudolinfomatosa. 115
Topical Corticosteroid Phobia Among Women Affected With Vulvar Lichen Sclerosus: Results From a Cross-sectional Survey 115
Dermoscopy of vulvar multiple syringomas: a diagnostic aid for a rare entity 112
null 112
Successful treatment of ectropion induced by actinic keratoses with photodynamic therapy: Report of two cases 111
Hidradenitis suppurativa: medical and surgical therapy review. 109
Pioderma gangrenoso recidivante del volto trattato con dapsone. 109
Proposal of a self-assessment questionnaire for the diagnosis of sensitive skin 107
Lichen sclerosus vulvare: caratteristiche clinico-epidemiologiche, fattori di rischio ed elementi prognostici in pazienti seguite c/o l’ambulatorio di patologia vulvare. 106
When traditional Chinese medicine runs on WhatsApp® 103
Continuous vs. tapering application of the potent topical corticosteroid mometasone furoate in the treatment of vulvar lichen sclerosus: Results of a randomized trial 97
Paget mammario pigmentato 96
null 95
Searching for a “Window of Opportunity” in the Treatment of Vulvar Lichen Sclerosus: Evidence for Therapeutic Benefits of an Early Corticosteroid Treatment 89
Real-World Safety of Oral Isotretinoin in Patients During Sunny Months: Retrospective Cohort Study 85
Dermoscopy in plasma cell balanitis: its usefulness in diagnosis and follow-up. 85
null 83
Onychomadesis following hand, foot, and mouth disease: a case report from Italy and review of the literature. 73
Totale 25.715
Categoria #
all - tutte 67.629
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 905
Totale 68.534


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.761 154 205 135 151 129 81 115 94 90 147 141 319
2022/20232.570 223 188 126 191 237 208 184 165 229 177 271 371
2023/20243.792 352 395 329 291 245 279 234 235 189 349 443 451
2024/20255.051 539 500 458 291 495 406 316 352 505 423 392 374
2025/20266.662 620 381 615 664 840 478 735 400 531 731 321 346
2026/2027298 298 0 0 0 0 0 0 0 0 0 0 0
Totale 25.715